VBI Vaccines

About:

VBI Vaccinea is a biopharmaceutical company developing novel technologies that seek to expand vaccine.

Website: http://www.vbivaccines.com/

Twitter/X: vbivaccines

Top Investors: ARCH Venture Partners, 5AM Ventures, Clarus Ventures

Description:

VBI Vaccines is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines that closely mimic the target virus. VBI is headquartered in Cambridge, MA with research facilities in Ottawa, Canada.

Total Funding Amount:

$68.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2001-01-01

Contact Email:

info(AT)VBIvaccines.com

Founders:

David Anderson

Number of Employees:

101-250

Last Funding Date:

2015-08-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai